These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

503 related items for PubMed ID: 10850437

  • 1. Enhancement of Fas-mediated apoptosis in renal cell carcinoma cells by adriamycin.
    Wu XX, Mizutani Y, Kakehi Y, Yoshida O, Ogawa O.
    Cancer Res; 2000 Jun 01; 60(11):2912-8. PubMed ID: 10850437
    [Abstract] [Full Text] [Related]

  • 2. Sensitization of human bladder cancer cells to Fas-mediated cytotoxicity by cis-diamminedichloroplatinum (II).
    Mizutani Y, Yoshida O, Bonavida B.
    J Urol; 1998 Aug 01; 160(2):561-70. PubMed ID: 9679929
    [Abstract] [Full Text] [Related]

  • 3. Synergistic cytotoxicity and apoptosis by Apo-2 ligand and adriamycin against bladder cancer cells.
    Mizutani Y, Yoshida O, Miki T, Bonavida B.
    Clin Cancer Res; 1999 Sep 01; 5(9):2605-12. PubMed ID: 10499639
    [Abstract] [Full Text] [Related]

  • 4. Sensitization of human renal cell carcinoma cells to cis-diamminedichloroplatinum(II) by anti-interleukin 6 monoclonal antibody or anti-interleukin 6 receptor monoclonal antibody.
    Mizutani Y, Bonavida B, Koishihara Y, Akamatsu K, Ohsugi Y, Yoshida O.
    Cancer Res; 1995 Feb 01; 55(3):590-6. PubMed ID: 7834629
    [Abstract] [Full Text] [Related]

  • 5. Interferon-gamma-induced sensitization of colon carcinomas to ZD9331 targets caspases, downstream of Fas, independent of mitochondrial signaling and the inhibitor of apoptosis survivin.
    Geller J, Petak I, Szucs KS, Nagy K, Tillman DM, Houghton JA.
    Clin Cancer Res; 2003 Dec 15; 9(17):6504-15. PubMed ID: 14695155
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Enhancement of the sensitivity of renal cell carcinoma cells to fas-mediated cytotoxicity and apoptosis by the selective cyclooxygenase-2 inhibitor JTE-522.
    Sato N, Mizutani Y, Li YN, Fujiwara J, Ishida H, Toiyama D, Abe K, Hayashi I, Nakanishi H, Kawauchi A, Miki T.
    Urol Int; 2010 Dec 15; 84(3):362-8. PubMed ID: 20389170
    [Abstract] [Full Text] [Related]

  • 8. The CD95/CD95 ligand system is not the major effector in anticancer drug-mediated apoptosis.
    Tolomeo M, Dusonchet L, Meli M, Grimaudo S, D'Alessandro N, Papoff G, Ruberti G, Rausa L.
    Cell Death Differ; 1998 Sep 15; 5(9):735-42. PubMed ID: 10200532
    [Abstract] [Full Text] [Related]

  • 9. Enhancement of arsenic trioxide-induced apoptosis in renal cell carcinoma cells by L-buthionine sulfoximine.
    Wu XX, Ogawa O, Kakehi Y.
    Int J Oncol; 2004 Jun 15; 24(6):1489-97. PubMed ID: 15138592
    [Abstract] [Full Text] [Related]

  • 10. Enhanced sensitivity of bladder cancer cells to tumor necrosis factor related apoptosis inducing ligand mediated apoptosis by cisplatin and carboplatin.
    Mizutani Y, Nakao M, Ogawa O, Yoshida O, Bonavida B, Miki T.
    J Urol; 2001 Jan 15; 165(1):263-70. PubMed ID: 11125422
    [Abstract] [Full Text] [Related]

  • 11. Mechanism(s) of antitumor action in protracted infusion of low dose 5-fluorouracil and cisplatin in gastric carcinoma.
    Kim R, Tanabe K, Inoue H, Toge T.
    Int J Oncol; 2002 Mar 15; 20(3):549-55. PubMed ID: 11836567
    [Abstract] [Full Text] [Related]

  • 12. FTY720 induced Bcl-associated and Fas-independent apoptosis in human renal cancer cells in vitro and significantly reduced in vivo tumor growth in mouse xenograft.
    Ubai T, Azuma H, Kotake Y, Inamoto T, Takahara K, Ito Y, Kiyama S, Sakamoto T, Horie S, Muto S, Takahara S, Otsuki Y, Katsuoka Y.
    Anticancer Res; 2007 Mar 15; 27(1A):75-88. PubMed ID: 17352219
    [Abstract] [Full Text] [Related]

  • 13. Role of the Fas/FasL pathway in combination therapy with interferon-alpha and fluorouracil against hepatocellular carcinoma in vitro.
    Nakamura M, Nagano H, Sakon M, Yamamoto T, Ota H, Wada H, Damdinsuren B, Noda T, Marubashi S, Miyamoto A, Takeda Y, Umeshita K, Nakamori S, Dono K, Monden M.
    J Hepatol; 2007 Jan 15; 46(1):77-88. PubMed ID: 17045692
    [Abstract] [Full Text] [Related]

  • 14. Interferon-alpha and interferon-gamma sensitize human tenon fibroblasts to mitomycin-C.
    Wang XY, Crowston JG, Zoellner H, Healey PR.
    Invest Ophthalmol Vis Sci; 2007 Aug 15; 48(8):3655-61. PubMed ID: 17652735
    [Abstract] [Full Text] [Related]

  • 15. Chemosensitization of human prostate carcinoma cell lines to anti-fas-mediated cytotoxicity and apoptosis.
    Uslu R, Borsellino N, Frost P, Gárban H, Ng CP, Mizutani Y, Belldegrun A, Bonavida B.
    Clin Cancer Res; 1997 Jun 15; 3(6):963-72. PubMed ID: 9815772
    [Abstract] [Full Text] [Related]

  • 16. Apoptotic behaviour of hepatic and extra-hepatic tumor cell lines differs after Fas stimulation.
    Lamboley C, Bringuier AF, Feldmann G.
    Cell Mol Biol (Noisy-le-grand); 2000 Feb 15; 46(1):13-28. PubMed ID: 10726968
    [Abstract] [Full Text] [Related]

  • 17. Significant antitumoral activity of cationic multilamellar liposomes containing human IFN-beta gene against human renal cell carcinoma.
    Nakanishi H, Mizutani Y, Kawauchi A, Ukimura O, Shiraishi T, Hatano M, Mizuno M, Yoshida J, Miki T.
    Clin Cancer Res; 2003 Mar 15; 9(3):1129-35. PubMed ID: 12631618
    [Abstract] [Full Text] [Related]

  • 18. Activation of caspase-3 in renal cell carcinoma cells by anthracyclines or 5-fluorouracil.
    Wu XX, Kakehi Y, Mizutani Y, Lu J, Terachi T, Ogawa O.
    Int J Oncol; 2001 Jul 15; 19(1):19-24. PubMed ID: 11408917
    [Abstract] [Full Text] [Related]

  • 19. Resistance to CD95 (APO-1/Fas)-mediated apoptosis in human renal cell carcinomas: an important factor for evasion from negative growth control.
    Gerharz CD, Ramp U, Déjosez M, Mahotka C, Czarnotta B, Bretschneider U, Lorenz I, Müller M, Krammer PH, Gabbert HE.
    Lab Invest; 1999 Dec 15; 79(12):1521-34. PubMed ID: 10616203
    [Abstract] [Full Text] [Related]

  • 20. Adriamycin sensitizes the adriamycin-resistant 8226/Dox40 human multiple myeloma cells to Apo2L/tumor necrosis factor-related apoptosis-inducing ligand-mediated (TRAIL) apoptosis.
    Jazirehi AR, Ng CP, Gan XH, Schiller G, Bonavida B.
    Clin Cancer Res; 2001 Dec 15; 7(12):3874-83. PubMed ID: 11751478
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 26.